Swine Flu Epidemic An excess over the expected incidence of disease within a geographical area during a specified time period Flu Terms Defined
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
First name of a flu virus is the H#
Last name of a flu virus is the N#
human infections can and do happen
spread from person-to-person, but in the
past, this transmission was limited and
not sustained beyond three people
Phase 5is characterized by human-to-human spread of the virus into at least two countries in one WHO region. While most countries will not be affected at this stage, the declaration of Phase 5 is a strong signal that a pandemic is imminent and that the time to finalize the organization, communication, and implementation of the planned mitigation measures is short.
Is this new H1N1 virus contagious?CDC has determined that this new H1N1 virus is contagious and is spreading from human to human. However, at this time, it is not known how easily the virus spreads between people.
then touching their mouth or nose.
Tap water that has been treated by conventional disinfection processes does not likely pose a risk for transmission of influenza viruses.
Linens, eating utensils, and dishes belonging to those who are sick do not need to be cleaned separately, but importantly these items should not be shared without washing thoroughly first.
Linens (such as bed sheets and towels) should be washed by using household laundry soap and tumbled dry on a hot setting.
Individuals should avoid “hugging” laundry prior to washing it to prevent contaminating themselves.
Individuals should wash their hands with soap and water or alcohol-based hand rub immediately after handling dirty laundry.
High-risk groups:A person who is at high-risk for complications of novel influenza (H1N1) virus infection is defined as the same for seasonal influenza at this time. As more epidemiologic and clinical data become available, these risk groups might be revised.
symptoms of seasonal flu in humans and may include:
vomiting associated with swine flu.
a worsening of underlying chronic medical conditions.
and after food preparation and in-out of toilets. Regular wash your
you develop influenza-like symptoms. (High Fever, body pain, coughing and red nose)
of germs that cause respiratory illnesses like influenza.
Take these everyday steps to protect your health:
sneeze.Throw the tissue in the trash after you use it
you cough or sneeze. Alcohol-based hand cleaners are also
coughing or sneezing. It may prevent those
around you from getting sick.
Put your used tissue in the waste basket.
virus causing illness in humans.
It is not known whether current human seasonal influenza vaccines can provide any protection.
vaccine against the currently circulating virus strain for it to
provide maximum protection to the vaccinated people. This is
why WHO needs access to as many viruses as possible in order
to select the most appropriate candidate vaccine virus.
There are two influenza antiviral medications that are recommended for use against H1N1 flu. The drugs that are used for treating H1N1 flu are called oseltamivir (trade name Tamiflu ®) and zanamivir (Relenza ®).
Antiviral drugs are prescription medicines (pills, liquid or an inhaler) that fight against the flu by keeping flu viruses from reproducing in your body.
If you get sick, antiviral drugs can make your illness milder and make you feel better faster.
They may also prevent serious flu complications. During the current outbreak, the priority use for influenza antiviral drugs during is to treat severe influenza illness.
-All of government involved
-Link of plans of private Entities and voluntary sector
-Involve Civil Defence
-Priority to Public Information
-Action items indicated
-Responsible Bodies Identified
-Emphesis on Communicating information to public
Plan must be revised regularly
CDC works very closely with state and local officials in areas where human cases of new H1N1 flu infections have been identified. In California and Texas, where EpiAid teams have been deployed, many epidemiological activities are taking place or planned including:
Active surveillance in the counties where infections in humans have been identified;
Who is in charge of medicine in the Strategic National Stockpile (SNS) once it is deployed?
Information provided by states and local health authorities should be consulted to determine whether public health authorities are advising that patients who test positive on a rapid influenza antigen test need additional testing.
In areas with no or few confirmed cases of novel H1N1 flu, a nasopharyngeal swab/aspirate or nasal aspirate should be collected and sent to the state public health laboratory for RT-PCR to determine if the patient has H1N1 infection, seasonal influenza A virus infection, or a false-positive test result.
The specimen should be placed in a 4°C refrigerator (not a freezer) or immediately placed on ice or cold packs for transport to the laboratory.
distributed test kits to all states in the U.S. and the District of Columbia and Puerto Rico. The test kits are being shipped internationally as well. This will allow states and other countries to test for this new virus. This increase in testing will likely result in an increase in the number of confirmed cases of illness reported. This, combined with ongoing monitoring through Flu View should provide a fuller picture of the burden of disease in the United States over time
The reliability of rapid influenza diagnostic tests depends largely on the conditions under which they are used, and are entirely based on the experience with seasonal influenza.
False-positive (and true-negative) results are more likely to occur when influenza is uncommon in the community, which is generally at the beginning and end of an outbreak.
How to interpret a negative result: Novel H1N1 flu virus infection cannot be excluded when a patient tests negative for influenza A by rapid antigen test.
Other tests. Immunofluorescence (DFA or IFA) tests can distinguish between influenza A and B viruses.
(A) In communities where swine influenza A (H1N1) virus transmission is occurring
healthcare personnel should be monitored daily for signs and symptoms of febrile respiratory illness.
close contact with a person who is a confirmed, probable, or suspected case of swine influenza A (H1N1) virus infection, within the past 7 days OR
Procedures that are likely to generate aerosols (e.g., bronchoscopy, elective intubation, suctioning, administering nebulized medications), should be done in a location with negative pressure air handling whenever feasible.
Procedures for transport of patients in isolation precautions should be followed.
Standard and Contact precautions plus eye protection should be used for all patient care activities for patients being evaluated or in isolation for swine influenza A (H1N1) (i.e., including all healthcare personnel who enter the patient’s room).
Respiratory protection: All healthcare personnel who enter the rooms of patients in isolation for swine influenza should wear a fit-tested disposable N95 respirator or equivalent (e.g., powered air purifying respirator)*.